Morgan Stanley Maintains Equal-Weight on TransMedics Gr, Lowers Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong has maintained an Equal-Weight rating on TransMedics Gr (NASDAQ:TMDX) but lowered the price target from $81 to $50.
October 13, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on TransMedics Gr but lowered the price target from $81 to $50.
The lowering of the price target by Morgan Stanley indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100